BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 18294862)

  • 21. Angiotensin II-induced vasodilation via type 2 receptor: role of bradykinin and nitric oxide.
    Yayama K; Okamoto H
    Int Immunopharmacol; 2008 Feb; 8(2):312-8. PubMed ID: 18182246
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peroxisome proliferator-activated receptor alpha activation attenuated angiotensin type 1-mediated but enhanced angiotensin type 2-mediated hemodynamic effects to angiotensin II in the rat.
    Banks T; Oyekan A
    J Hypertens; 2008 Mar; 26(3):468-77. PubMed ID: 18300857
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Renal and hormonal responses to direct renin inhibition with aliskiren in healthy humans.
    Fisher ND; Jan Danser AH; Nussberger J; Dole WP; Hollenberg NK
    Circulation; 2008 Jun; 117(25):3199-205. PubMed ID: 18559696
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Update: role of the angiotensin type-2 (AT(2)) receptor in blood pressure regulation.
    Carey RM; Wang ZQ; Siragy HM
    Curr Hypertens Rep; 2000 Apr; 2(2):198-201. PubMed ID: 10981149
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Angiotensin II-mediated vasodilation is reduced in adult spontaneously hypertensive rats despite enhanced expression of AT2 receptors.
    Ognibene DT; Oliveira PR; Marins de Carvalho LC; Costa CA; Espinoza LA; Criddle DN; Tano T; Soares de Moura R; Resende AC
    Clin Exp Pharmacol Physiol; 2009 Jan; 36(1):12-9. PubMed ID: 18986337
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Non-peptide AT2-receptor agonists.
    Steckelings UM; Larhed M; Hallberg A; Widdop RE; Jones ES; Wallinder C; Namsolleck P; Dahlöf B; Unger T
    Curr Opin Pharmacol; 2011 Apr; 11(2):187-92. PubMed ID: 21167778
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of angiotensin II and its metabolites in the rat coronary vascular bed: is angiotensin III the preferred ligand of the angiotensin AT2 receptor?
    van Esch JH; Oosterveer CR; Batenburg WW; van Veghel R; Jan Danser AH
    Eur J Pharmacol; 2008 Jul; 588(2-3):286-93. PubMed ID: 18511032
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Angiotensin II receptor blocker inhibits tumour necrosis factor-alpha-induced cell damage in human renal proximal tubular epithelial cells.
    Kagawa T; Takao T; Horino T; Matsumoto R; Inoue K; Morita T; Hashimoto K
    Nephrology (Carlton); 2008 Jun; 13(4):309-15. PubMed ID: 18331441
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Angiotensin II type 1 and type 2 receptor].
    Akazawa H; Komuro I
    Nihon Rinsho; 2009 Apr; 67(4):687-94. PubMed ID: 19348229
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Angiotensin II type 2 receptor gene deletion does not affect renin-angiotensin system].
    Li WG; Chen XM; Ye YZ; Zhang Y; Yu LF
    Sheng Li Xue Bao; 1998 Aug; 50(4):460-4. PubMed ID: 11324558
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Angiotensin II type 2 receptor effect on microvascular hydraulic permeability.
    Newton CR; Curran B; Victorino GP
    J Surg Res; 2004 Jul; 120(1):83-8. PubMed ID: 15172193
    [TBL] [Abstract][Full Text] [Related]  

  • 32. AT2 receptors: beneficial counter-regulatory role in cardiovascular and renal function.
    Padia SH; Carey RM
    Pflugers Arch; 2013 Jan; 465(1):99-110. PubMed ID: 22949090
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Angiotensin II type 2 receptor provides an endogenous brake during inflammation-induced microvascular fluid leak.
    Ereso AQ; Ramirez RM; Sadjadi J; Cripps MW; Cureton EL; Curran B; Victorino GP
    J Am Coll Surg; 2007 Oct; 205(4):527-33. PubMed ID: 17903725
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of angiotensin II and endogenous vasodilators in the control of glomerular hemodynamics.
    Arima S
    Clin Exp Nephrol; 2003 Sep; 7(3):172-8. PubMed ID: 14586712
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insights into angiotensin II receptor function through AT2 receptor knockout mice.
    Gross V; Obst M; Luft FC
    Acta Physiol Scand; 2004 Aug; 181(4):487-94. PubMed ID: 15283762
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of the angiotensin AT2 receptor in blood pressure regulation and therapeutic implications.
    Carey RM; Jin XH; Siragy HM
    Am J Hypertens; 2001 Jun; 14(6 Pt 2):98S-102S. PubMed ID: 11411772
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Angiotensin II subtype AT1 and AT2 receptors regulate microvascular hydraulic permeability via cAMP and cGMP.
    Chong TJ; Victorino GP
    J Surg Res; 2006 Mar; 131(1):105-10. PubMed ID: 16256138
    [TBL] [Abstract][Full Text] [Related]  

  • 38. AT2 Receptor Activation Prevents Sodium Retention and Reduces Blood Pressure in Angiotensin II-Dependent Hypertension.
    Kemp BA; Howell NL; Keller SR; Gildea JJ; Padia SH; Carey RM
    Circ Res; 2016 Aug; 119(4):532-43. PubMed ID: 27323774
    [TBL] [Abstract][Full Text] [Related]  

  • 39. AT1 and AT2 receptor in the kidney: role in health and disease.
    Siragy HM
    Semin Nephrol; 2004 Mar; 24(2):93-100. PubMed ID: 15017521
    [TBL] [Abstract][Full Text] [Related]  

  • 40. AT
    Ali Q; Hussain T
    Int J Clin Pharmacol Toxicol; 2012 Oct; 1(1):15-19. PubMed ID: 27588222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.